Effects of self-help mindfulness-based cognitive therapy on mindfulness, symptom change, and suicidal ideation in patients with depression: a randomized controlled study.
Yuanyuan Mo, Zhiying Lei, Mei Chen, Hongyan Deng, Rong Liang, Miaoyu Yu, Huiqiao Huang
Frontiers in psychology January 1, 2023 DOI: 10.3389/fpsyg.2023.1287891
Summary
Self-help mindfulness-based cognitive therapy (MBCT-SH) significantly enhances mindfulness and reduces symptoms of depression and suicidal thoughts. In a randomized controlled study with 97 participants, 96% of those in the MBCT-SH group completed the eight-week program. By the end of the intervention, significant improvements were observed in mindfulness and depression scores compared to the control group. Additionally, treatment costs were 5,298 RMB lower for MBCT-SH participants, while readmission rates remained comparable at 6-month follow-up, highlighting MBCT-SH's effectiveness and cost-efficiency for managing depression.
Abstract
This study aimed to evaluate the effects of self-help mindfulness-based cognitive therapy (MBCT-SH) on mindfulness, symptom change, and suicidal ideation in patients with depression. For this randomized controlled study, 97 patients were randomly assigned to either the MBCT-SH (n = 48) or control (n = 49) group. The Five Facet Mindfulness Questionnaire (FFMQ), Hamilton Depression Rating Scale (HAMD-24), and Suicide Attitude Questionnaire (SAQ) were used to assess mindfulness, depression symptoms, and suicidal ideation, respectively, at baseline (T0), intervention week 4 (T1), intervention week 8 (T2), and 3-month follow-up (T3). The groups were also compared on treatment costs and readmission rates at a 6-month follow-up. In the MBCT-SH group, 46 of 48 participants (96%) completed the eight-week program. At T0, there were no statistically significant between-group differences in demographics, clinical characteristics, FFMQ, HAMD-24, or SAQ. Nor were there statistically significant differences on the HAMD-24 or SAQ between the MBCT-SH and control groups at T1 (p = 0.18 and p = 0.59, respectively), while mindfulness was significantly higher in the MBCT-SH group (t = 2.383, p = 0.019). At T2, there were significant between-group differences on the FFMQ, HAMD-24, and SAQ, all of which remained significant at T3. At the 6-month follow-up, per capita treatment costs were 5,298 RMB lower in the MBCT-SH group compared with the control group, while their readmission rates (6.1% and 4.2%, respectively) did not differ significantly. These findings support the feasibility and effectiveness of MBCT-SH among patients with depression. http://www.chictr.org.cn, ChiCTR2300077850.